Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
HKSE 2196.HK
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Revenue Per Share for the year ending December 31, 2023: USD 2.17
-
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Revenue Per Share for the year ending December 31, 2022 was USD 2.44, a 1.65% change year over year.
-
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Revenue Per Share for the year ending December 31, 2021 was USD 2.40, a 32.49% change year over year.
-
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Revenue Per Share for the year ending December 31, 2020 was USD 1.81, a 12.83% change year over year.
-
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Revenue Per Share for the year ending December 31, 2019 was USD 1.61, a 11.85% change year over year.
| Date | Revenue Per Share | Dividend Per Share | Free Cash Flow Per Share | Return on Assets (ROA) |
|---|
| CEO | Mr. Deyong Wen |
| IPO Date | Oct. 30, 2012 |
| Location | China |
| Headquarters | Building A |
| Employees | 40,370 |
| Sector | Health Care |
| Industries | |
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, metabolism, alimentary and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Past 5 years
USD 1.58
USD 2.59
USD 0.37
USD 2.26
StockViz Staff
January 15, 2025
Any question? Send us an email